InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Skolnick Phil, Directeur Scientifique. Insider active across 1 company, notably Opiant Pharmaceuticals, INC.. Cumulatively, 9 reports have been published. Breakdown: 0 buy · 6 sells. Total volume traded: €96k. Activity tracked since 4 January 2022. The latest transaction was disclosed on 2 March 2023 (Disposition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Skolnick Phil
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
9,812 shares@ US$20.0056.5% of flowCommon StockSEC:0001385508-23-000065:0
480 shares@ US$20.262.7% of flowCommon StockSEC:0001385508-23-000031:0
369 shares@ US$20.202.1% of flowCommon StockSEC:0001385508-23-000020:0
1,421 shares@ US$20.208.3% of flowCommon StockSEC:0001385508-23-000007:0
627 shares@ US$11.852.3% of flowCommon StockSEC:0001385508-22-000111:0
2,000 shares0Common StockSEC:0001385508-22-000101:0
1,518 shares@ US$26.1938.7% of flowCommon StockSEC:0001385508-22-000026:0
385 shares@ US$30.4911.3% of flowCommon StockSEC:0001385508-22-000021:0
12,000 shares0Common StockSEC:0001385508-22-000013:0
9 of 9 declarations
About Skolnick Phil
Phil Skolnick is Chief Scientific Officer at Opiant Pharmaceuticals, Inc. He is responsible for the scientific direction of the company, overseeing research and development of new products. His expertise is essential for innovation and the success of Opiant Pharmaceuticals.
